Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025)
Siga Technologies' (SIGA) quarterly Other Accumulated Expenses came in at $869431.0 in Q4 2025, down 59.75% YoY from $2.2 million in Q4 2024, and down 22.8% on a QoQ basis from $1.1 million in Q3 2025.
Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 7 years of Other Accumulated Expenses data on file, last reported at $869431.0 in Q4 2025.
- Quarterly Other Accumulated Expenses fell 59.75% year-over-year to $869431.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $869431.0 (down 59.75% YoY) and the FY2025 annual result came in at $869431.0, down 59.75% from the prior year.
- Other Accumulated Expenses declined to $869431.0 in Q4 2025, from $1.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q1 2025 to a low of $278788.0 in Q2 2021.
- A 5-year average of $1.3 million and a median of $1.2 million in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses tumbled 70.15% — and 2022, when it jumped 235.29%.
- Tracing SIGA's Other Accumulated Expenses over 5 years: stood at $1.4 million in 2021, then retreated by 10.4% to $1.3 million in 2022, then jumped by 63.36% to $2.1 million in 2023, then rose by 3.49% to $2.2 million in 2024, then slumped by 59.75% to $869431.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $869431.0 (Q4 2025), $1.1 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 869,431.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 852,370.00 |
| Jun 30, 2022 | 934,745.00 |
| Mar 31, 2022 | 753,540.00 |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 416,966.00 |
| Jun 30, 2021 | 278,788.00 |
| Mar 31, 2021 | 286,476.00 |